Features | Partner Sites | Information | LinkXpress
Sign In
GLOBETECH PUBLISHING
JIB
GLOBETECH PUBLISHING

Indian Spice Ingredient Kills Cancer Cells

By BiotechDaily International staff writers
Posted on 10 Nov 2009
A new study has revealed that curcumin, a compound found in the spice Turmeric, kills esophageal cancer cells in the laboratory via an unforeseen cell-death mechanism.

Researchers at University College Cork (UCC, Ireland) found that curcumin treatment of an esophageal cancer cell line reduced the viability of all cells within 24 hours of treatment. Since the common path of cell death is apoptosis--a cell suicide path triggered by proteins called caspases--the researchers added a molecule that stops the caspases triggering apoptosis, and found that it made no difference to the number of cells that died. The curcumin seems to induce cell death by a mechanism that was not reliant on apoptosis induction, and in fact, the cells began to digest themselves. The study was published in the October 28, 2009, issue of the British Journal of Cancer.

"The incidence of esophageal cancer has gone up by more than a half since the 70's, particularly in the Western world, and this is thought to be linked to rising rates of obesity, alcohol intake and reflux disease, so finding ways to both treat and prevent this disease is extremely important,” said study coauthor Professor Gerald O'Sullivan, M.D., Ph.D., who heads the Cork Cancer Research Center (CCRC) at UCC. "The development of natural compounds as chemo-preventative agents is also a very promising area of research.”

Curcumin is the principal curcuminoid of the ginger family (Zingiberaceae); the other two curcuminoids are desmethoxycurcumin and bis-desmethoxycurcumin. The curcuminoids are polyphenols and thus responsible for the yellow color of turmeric, which has been used historically as a component of Indian Ayurvedic medicine since 1900 BCE to treat a wide variety of ailments. A recent study on curcumin effects on cancer stated that curcumin modulates growth of tumor cells through regulation of multiple cell signaling pathways, including the cell proliferation pathway, cell survival pathway, caspase activation pathway, tumor suppressor pathway, death receptor pathway, mitochondrial pathways, and the protein kinase pathway.

Related Links:

University College Cork



comments powered by Disqus

Channels

Genomics/Proteomics

view channel
Image: Alternative splicing produces two protein isoforms (Photo courtesy of Wikimedia Commons).

Key Regulator of Cancer-Inducing Alternative Splicing Identified

Cancer researchers have identified the splicing factor RBM4 (RNA-binding protein 4) as a key determinant in processes that prevent tumor development and spread. RBM4 is known to be crucial to gene splicing... Read more

Drug Discovery

view channel

Ibuprofen May Restore Immune Function in Older Individuals

New research suggests that macrophages from the lungs of old mice respond differently to infections than those of young mice, and ibuprofen given to the mice reversed these changes. New research using lab mice suggests that the solution to more youthful immune function might already be a common over-the-counter pain reliever.... Read more

Therapeutics

view channel
Image: Hair follicle (blue) being attacked by T cells (green) (Photo courtesy of Christiano Lab/Columbia University Medical Center).

Hair Restoration Method Clones Patients’ Cells to Grow New Hair Follicles

Researchers have developed of a new hair restoration approach that uses a patient’s cells to grow new hair follicles. In addition, the [US] Food and Drugs Administration (FDA) recently approved a new drug... Read more

Lab Technologies

view channel
Image: Leica Microsystems launches the inverted research microscope platform Leica DMi8 (Photo courtesy of Leica Microsystems).

New Inverted Microscope Designed to Readily Adapt to Changing Research Demands

A new inverted microscope for biotech and other life science laboratories was designed to readily accommodate modifications and upgrades to allow it to keep current with changing research demands and interests.... Read more

Business

view channel

Partnership Established to Decode Bowel Disease

23andMe (Mountain View, CA,USA), a personal genetics company, is collaborating with Pfizer, Inc. (New York, NY, USA), in which the companies will seek to enroll 10,000 people with inflammatory bowel disease (IBD) in a research project designed to explore the genetic factors associated with the onset, progression, severity,... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.